In just over two months the NHS said it had given 124,867 RSV vaccinations to eligible pregnant woman and elderly people, who were being offered the vaccine for the first time. The NHS has ...
COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).
In June, the FDA expanded the approval of GSK's RSV vaccine (Arexvy) for use in adults ages 50 to 59 at risk of RSV-related lower respiratory tract disease due to underlying conditions ...